Consciousness loss may occur after bouts of laughter in individuals diagnosed with Angelman syndrome
In a groundbreaking article published in Epilepsy & Behavior Reports in 2003, the phenomenon of gelastic syncope in people with Angelman syndrome was explored. This genetic disorder, characterised by developmental and behavioural abnormalities, often leaves individuals prone to intense bouts of laughter.
The article, titled "Gelastic spells in Angelman Syndrome, when laughter isn't funny," highlights the importance of understanding and managing gelastic syncope. This condition, where laughter can lead to a loss of consciousness, is one of the potential explanations for the gelastic spells observed in Angelman patients.
Distinguishing between seizures, cataplexy, and gelastic syncope is crucial to guiding treatment in Angelman patients. While seizures are often managed with anti-seizure medicines, antidepressants are typically effective for controlling cataplexy. However, data are limited on whether particular medications are effective in Angelman patients experiencing gelastic syncope.
The article describes the experiences of three Angelman patients who had repeated episodes of laughter followed by loss of consciousness, sometimes leading to collapse. In such cases, the first-line management involves limiting time spent standing up, ensuring the patient drinks lots of fluids, and consuming more salt to help keep blood pressure up. If first-line management doesn't work, medications such as antidepressants may be tried.
An alternative to measuring brain activity is using EKGs, which can be done at home with worn devices, to detect changes in heart rate that confirm or rule out gelastic syncope. Measuring the brain's electrical activity during an episode can help distinguish seizures and syncope, but this is often impractical. Detailed clinical histories and extensive talks with caregivers, along with home video recordings, can help differentiate between these phenomena.
The study on gelastic syncope in Angelman syndrome emphasises the need for further studies to explore laughter-related episodes in Angelman patients and to test treatment options. Recent developments include the first patient in the Phase 3 Aspire trial of gene therapy GTX-102 being signed up.
For those interested in staying updated on the latest research and developments in Angelman syndrome, subscribing to the Angelman Syndrome newsletter agrees to the Terms of Service and Privacy Policy.
It is important to remember that people with Angelman syndrome tend to be very happy and prone to laughter. However, understanding and managing gelastic syncope is a crucial step towards improving the quality of life for those living with this condition. The article serves as a call to action for clinicians and caregivers to be aware of this phenomenon and to help form a framework for diagnosis, data collection, and treatment.
Read also:
- Understanding Hemorrhagic Gastroenteritis: Key Facts
- Stopping Osteoporosis Treatment: Timeline Considerations
- Tobacco industry's suggested changes on a legislative modification are disregarded by health journalists
- Expanded Community Health Involvement by CK Birla Hospitals, Jaipur, Maintained Through Consistent Outreach Programs Across Rajasthan
